Overview
Recognise autonomous nodular hyperthyroidism, define structural and functional risk, and choose durable radioiodine or surgical treatment while controlling cardiovascular consequences.
Autonomy develops when thyroid tissue produces hormone without normal TSH control. In multinodular disease, multiple clones create heterogeneous function; in an adenoma, a single clone dominates. Longstanding iodine deficiency and increasing age contribute epidemiologically, while an iodine load can uncover previously compensated autonomy. Unlike Graves disease, there is no autoimmune remission target and eye disease is not a characteristic feature.
Clinical priority often lies outside the neck. Persistent even mild hormone excess increases risk of atrial fibrillation, heart failure and bone loss, especially in older adults. A patient can appear relatively calm yet have substantial cardiac morbidity. Evaluate pulse rhythm, exercise tolerance, falls or fracture risk, weight change and cognition alongside the thyroid profile.
Functional and structural assessments answer different questions. Scintigraphy maps autonomy; ultrasound characterises nodules and cervical nodes when a palpable or imaging-detected lesion requires risk stratification. A low TSH should be communicated on the ultrasound request. Compression, retrosternal extension or suspicious lymphadenopathy can make surgery appropriate even when radioiodine would otherwise control hormone excess.